Beacon Equity Research: TranS1 (TSON) Shares Drop more than 40% on Subpoena from Government
Shares of TranS1 Inc., a medical device company engaged in the designing, development and marketing of products that implement its minimally invasive surgical approach to treat degenerative disc disease, are down more than 40% this week. The huge sell-off in TranS1 shares was sparked after the company announced on Monday that it received a subpoena from the U.S. Department of Health and Human Services (HHS). In a regulatory filing, TranS1 said that HHS is seeking documents from January 1, 2011, through October 6, 2011. Although TranS1 claims that HHS has made no claims against it, the news triggered a huge…